These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3079091)

  • 1. Demonstration of strong classic immune reactivity after total-body irradiation for bone marrow transplantation. Implications for human T-depleted bone marrow transplantation.
    Gassmann W; von Kolszynski M; Wottge HU; Müller-Ruchholtz W
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2687-8. PubMed ID: 3079091
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of T cell-depleted bone marrow in histoincompatible rabbits: improved engraftment and long-term chimeras after the addition of irradiated donor buffy coat cells and irradiated autologous cryopreserved bone marrow.
    Gratwohl A; Baldomero H; Nissen C; Speck B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2756-7. PubMed ID: 3274587
    [No Abstract]   [Full Text] [Related]  

  • 4. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 7. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors.
    Schwartz E; Lapidot T; Gozes D; Singer TS; Reisner Y
    J Immunol; 1987 Jan; 138(2):460-5. PubMed ID: 3098843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of V beta T-cell receptor repertoire of effector mechanisms in acute and chronic graft versus host disease.
    Fischer AC; Ruvolo PP; Horwitz LR; Hess AD
    Transplant Proc; 1995 Feb; 27(1):1366-9. PubMed ID: 7878914
    [No Abstract]   [Full Text] [Related]  

  • 9. Thymectomy and severe combined immune-deficient bone marrow transplantation eradicates natural antibody of mice to human blood cells.
    Huppes W; Dijk J; Kinwel-Bohre EP; Van Bekkum DW
    Transplantation; 1993 Dec; 56(6):1568-9. PubMed ID: 8305084
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction of specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders.
    Slavin S; Karussis D; Weiss L; Vourka-Karussis U; Abramsky O
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1274-5. PubMed ID: 8442110
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological mechanisms governing tolerance to self-major histocompatibility complex antigens after bone marrow transplantation.
    Hess AD; Fischer AC; Horwitz LR; Bright EC; Hess JM
    Transplant Proc; 1995 Feb; 27(1):1370-3. PubMed ID: 7878915
    [No Abstract]   [Full Text] [Related]  

  • 12. Donor T cell and host NK depletion improve the therapeutic efficacy of allogeneic bone marrow cell reconstitution in the nonmyeloablatively conditioned tumor-bearing host.
    Hummel S; Wilms D; Vitacolonna M; Zöller M
    J Leukoc Biol; 2002 Nov; 72(5):898-912. PubMed ID: 12429711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
    J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells.
    Chowdhury NC; Jin MX; Hardy MA; Oluwole SF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):475-6. PubMed ID: 8438384
    [No Abstract]   [Full Text] [Related]  

  • 16. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
    Johnson BD; Drobyski WR; Truitt RL
    Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.
    Soderling CC; Song CW; Blazar BR; Vallera DA
    J Immunol; 1985 Aug; 135(2):941-6. PubMed ID: 3891856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of T cell-depleted bone marrow allografts in mice by thiotepa.
    Terenzi A; Lubin I; Lapidot T; Salomon O; Faktorowich Y; Rabi I; Martelli MF; Reisner Y
    Transplantation; 1990 Oct; 50(4):717-20. PubMed ID: 2120811
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP; Li Z; Nador RG; Strober S
    Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.